Photometric device detects early disease-related retinal changes and damage. Ophthalmology Times (August 1981).
Alm A, Tornquist P. Amino acid transport through the blood-retinal and the blood-brain barrier. Graefe’s Arch Clin Exp Ophthalmol 222:177-178 (1985).
Ando F, Goto S. Fundus manifestations in primary skin amyloidosis. Folia Ophthalmol Jpn 32:1087-1094 (1981).
Anstadt B, Blair NP, Rusin M, Cunha-Vaz JG, Tso M. Alteration of the blood-retinal barrier by sodium iodate: kinetic vitreous fluorophotometry and horseradish peroxidase tracer studies. Exp Eye Res 35:653-662 (1982). PubMed
Araie M, Maurice DM. The loss of fluorescein, fluorescein glucuronide, and fluorescein Isothiocyanate dextran from the vitreous by the anterior and retinal pathways. Exp Eye Res 52:27-39 (1991). PubMed
Araie M, Sugiura Y, Minota K, Akazawa K. Effects of the encircling procedure on the aqueous flow rate in retinal detachment eyes: A fluorometric study. Br J Ophthalmol 71: 510-515 (1987). PubMed
Archer DB, Gardiner TA, Sharma NK. The inner blood-retinal barrier in diabetes. Graefe’s Arch Clin Exp Ophthalmol 222:186-188 (1985).
Ashton N, Cunha-Vaz JG. Effect of histamine on the permeability of the ocular vessels. Arch Ophthalmol 73:211-222 (1965). PubMed
Bahgat M, Anis HH, Peyman GA, Farahat HG, Parry GJ, Khoobehi B. Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats. Int Ophthalmol 15(5):335-41 (1991). PubMed
Bakhda RN. Specialized Diagnostic Investigations to Assess Ocular Status in Hypertensive Diseases of Pregnancy. Diseases. 4(2):19 (2016). PubMed
Barsotti MF, Bartels SP, Kamm RD, Freddo TF. Background-protein effects on fluorophotometric data. Invest Ophthalmol Vis Sci 30:2046-2050 (1990). PubMed
Baurmann H, Chioralia G, Seifert H. Fluorescence microscopy study of fluorescein in the posterior segment of the eye following local application of drugs. Klin Monatsbl Augenheilkd 183:32-36 (1983). PubMed
Bellhorn RW, Korte GE. Permeability of abnormal blood-retinal barriers in rat phototoxic retinopathy: a clinicopathologic correlation study using fluorescent markers. Invest Ophthalmol Vis Sci 24:972-975 (1983). PubMed
Bellhorn RW, Lipman DA, Confino J, Burns MS. Effect of monosodium glutamate on retinal vessels development and permeability in rats. Invest Ophthalmol Vis Sci 21:237-247 (1981). PubMed
Bellhorn RW. Permeability of blood-ocular barriers of neonatal and adult cats to fluorescein-labeled dextrans of selected molecular sizes. Invest Ophthalmol Vis Sci 21:282-290 (1981). PubMed
Ben-Sira I, Riva CE. Biophysical aspects of microcirculation in the human fundus. Harefuah (Israel) 87:207-208 + 242 (1974). PubMed
Benitez del Castillo JM, Catillo A, Sanchez JG, Ruibal JL, Reverte F, Ibarra JM. An 18-month vitreous fluorophotometric follow-up study in juvenile diabetes. Acta Ophthalmol 71:651- (1993). PubMed
Benitez del Castillo JM, Ruibal JL, Reverte F, Seara G, Fernandez PC, Duran S, Casado E, Garcia Sanchez G. Growth hormone suppression with oral pirenzepine in insulin-dependent diabetics. A Study by Vitreous Fluorophotometry. J Fr Ophtalmol 17:110- (1994). PubMed
Berezovsky DE, Patel SR, McCarey BE, Edelhauser HF. In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits. Invest Ophthalmol Vis Sci 52(10):7038-45 (2011). PubMed
Berthet P, Farine JC, Barras JP. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy. Int J Clin Pract 53(8):631-6 (1999). PubMed
Bhattacharya M, Sadeghi A, Sarkhel S, Hagström M, Bahrpeyma S, Toropainen E, Auriola S, Urtti A. Release of functional dexamethasone by intracellular enzymes: A modular peptide-based strategy for ocular drug delivery. J Control Release 327:584-594 (2020). PubMed
Blair NP, Evans MA, Lesar TS, Zeimer RC. Fluorescein and fluorescein glucuronide pharmacokinetics after intravenous injection. Invest Ophthalmol Vis Sci 27:1107-1114 (1986). PubMed
Blair NP, Feigelman MJ, Zeimer RC, Rusin MM, Rhee AJ. Vitreous fluorophotometry after cataract surgery. Invest Ophthalmol Vis Sci 26(Suppl):30 (1985).
Blair NP, Feke GT, Morales-Stoppello J, Riva CE, Goser DG, Collas G, McMeel JW. Prolongation of the retinal mean circulation time in diabetes. Arch Ophthalmol 100:764-768 (1982). PubMed
Blair NP, Goldberg MG, Fishman GA, Salzano T. Autosomal dominant vitreoretinochoroidopathy (ADVIRC) Br J Ophthalmol 68:2-9 (1984). PubMed
Blair NP, Jones CW, Rusin MM. Pathophysiology of the blood-retinal barrier in experimental diabetes: Vitreous fluorophotometry using carboxyfluorescein and fluorescein. Arch Ophthalmol 102:1810-1814 (1984). PubMed
Blair NP, Zeimer RC, Rusin MM, Cunha-Vaz JG. Outward transport of fluorescein from the vitreous in normal human subjects. Arch Ophthalmol 101:1117-1121 (1983). PubMed
Blanksma LJ, Kooijman AC, Siertsema JV, Roze JH. Clinical applications of fluorophotometry. Doc Ophthalmol 55:37-40 (1983). PubMed
Bleicher SJ, Lee TY, Bernstein R, et al. Effect of blood glucose control on retinal vascular permeability in insulin-dependent diabetes mellitus. Diabetes Care 3:184-186 (1980). PubMed
Boot JP, Van Gerven JMA, Van Best JA, Vrij L, Lemkes HHPJ, Oosterhuis JA. Blood retinal and blood aqueous barriers in diabetics by fluorophotometry. Doc Ophthalmol 71:19 (1989). PubMed
Bordat B, Guirgis IR, Manderscheid JC. Vitreous Fluorophotometry in Diabetic Patients With No or Minimal Retinopathy. J Fr Ophthalmol 13:343- (1990). PubMed
Bordat B, Misse P, Zaluski S, Rouault R, Mirouze J. Surveillance par vitreofluorophotometrie de diabetiques traites par pompe a insuline, avec retinopathie absente ou minime. (Vitreofluorophotometric Follow-Up of Diabetic Patients Treated by Continuous Insulin Infusion With No or Min. Retinopathy: 3 Year Results .) J Fr Ophthal 12:421-425 (1989). PubMed
Borsje RA, Vrensen GFJM, van Best JA, Oosterhuis JA. Fluorophotometric determination of the function of the blood retinal barrier (cont) Supp Title: Abstracts from the 183rd Congress… Int Ophthalmol 13:478 (1989)
Borsje RA, Vrensin GFJM, van Best JA, Oosterhuis JA. Fluorophotometric determination of the blood retinal barrier after exposure to white light – Supp Title: Abstracts/183rd Congress… Int Ophthalmol 13:437 (1989).
Boxrud C, Yablonski ME, Fong N, Soleymani L, Cook DJ, Jovanovic L. Diabetic retinopathy and aqueous humor production. Invest Ophthalmol Vis Sci 26(Suppl):286 (1985).
Braude LS, Cunha-Vaz JG, Frenkel M. Vitreous fluorophotometry in optic nerve disease. Br J Ophthalmol 66:560-566 (1982). PubMed
Braude LS, Cunha-Vaz JG, Goldberg MF, Frenkel M, Hughes JR. Diagnosing acute retrobular neritis by vitreous fluorophotometry. Am J Ophthalmol 91:764-773 (1981). PubMed
Brooks AMV, Hussein CN, Chesterman JF, Martin JF, Alford FP, Penington DG. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy. Thromb Haemostas (Stuttgart) 49:123-127 (1983). PubMed
Brooks AMV, Keith CG, Court JM, Hill MA. Vitreous fluorophotometry in children with type-I diabetes-mellitus. Aust J Ophthalmol 12:39-43 (1984). PubMed
Bungay PM, Roy MS, Bonner RF. Posterior Vitreous Fluorophotometry: I. Description of a New Analysis Procedure and Results in Normal Subjects. Arch Ophthalmol:107:1321-1327 (1989). PubMed
Bursell SE, Delori FC, Yoshida A, Parker JS, Collas GD,McMeel JW. Vitreous fluorophotometric evaluation of diabetics. Invest Ophthalmol Vis Sci 25:703-710 (1984). PubMed
Buzney SM, Bartels SP, Macdonald SG, Frambach DA. An in vitro model of vascular leakage. Invest Ophthalmol Vis Sci 26(Suppl):171 (1985).
Canning P, Kenny BA, Prise V, Glenn J, Sarker MH, Hudson N, Brandt M, Lopez FJ, Gale D, Luthert PJ, Adamson P, Turowski P, Stitt AW. Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes. Proc Natl Acad Sci U S A. 28:7213-8 (2016). PubMed
Cantrill HL, Pederson JE. Experimental retinal detachment III. Vitreous fluorophotometry. Arch Ophthalmol 100:1810-1813 (1982). PubMed
Cantrill HL, Pederson JE. Experimental retinal detachment. VI. The permeability of the blood-retinal barrier. Arch Ophthalmol 102:747-751 (1984). PubMed
Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide 4(6):590-6 (2000). PubMed
Carney M, Paylor R, Cunha-Vaz J, Jampol LM, Goldberg MF. Choroidal neovascularization in sickle cell patients. Invest Ophthalmol Vis Sci 26(Suppl):23 (1985).
Cellini M, Baldi A. Vitreous fluorophotometric recordings in HIV infection. Int Ophthalmol 15:37- (1991). PubMed
Chahal P, Fallon TJ, Chowienczyk, Kohner EM. Quantitative changes in blood-retinal barrier function in central retinal vein occlusion. Trans Ophthalmol Soc U.K. 104:861-863 (1985). PubMed
Chahal PS, Fallon, TJ, Kohner EM. Measurement of blood-retinal barrier function in central retinal vein occlusion. Arch Ophthalmol 104:554-557 (1986). PubMed
Chaine G, Attali P, Gaudrie A, Colin MC, Quentel G, Coscas G. Ocular fluorophotometric and angiographic findings in toxemia of pregnancy. Arch Ophthalmol 104:1632-1635 (1986). PubMed
Chase, PH, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O’Brien D Glucose control and the renal and retinal complications of type I diabetes Draft.
Chen CL, Cheng WS, Chen JL, Chiang CH. Potential of Nonoral a-Lipoic Acid Aqueous Formulations to Reduce Ocular Microvascular Complications in a Streptozotocin-Induced Diabetic Rat Model. J Ocul Pharmacol Ther.29(8):738-45 (2013). PubMed
Chen S-C, Nakamura H, Tamura Z. Determination of fluorescein and fluorescein monoglucuronide excreted in urine. Chem Pharm Bull (Tokyo) 28:2812 (1980). PubMed
Clarici J, Cavazos ET, Gartner J. Vitreous fluorophotometry using oral fluorescein. I. A new type of vitreous fluorophotometer (German). Klin Monatsbl Augenheilkd 183:511-514 (1983). PubMed
Conway BP. An analysis of vitreous fluorophotometry. In: Retinal Diseases (S. I. Ryan, A. K. Dawson, H. L. Little eds). Grune and Stratton (Orlando) pp. 59-66 (1985).
Conway BP. Technical variables in vitreous fluorophotometry. Graefe’s Arch Clin Exp Ophthalmol 222:194-201 (1985). PubMed
Coscas G, Cunha-Vaz JG. Part 2: Chapter 25, Posterior segment fluorophotometry. Ophthalmology Today, p. 167.
Cunha-Vaz JG. A new perspective in diabetic retinopathy. In: New Directions In Ophthalmic Research edited by Dr. Marvin L. Sears. Yale University Press (New Haven & London) pp. 275-289 (1981).
Cunha-Vaz JG. Blood-retinal barriers in health and disease. Trans Ophthalmol Soc U.K. 100:337-340 (1980). PubMed
Cunha-Vaz JG. Desenvolvimento da fluorofotometria do vitreo. Actas IV Congresso Lus-Hispano-Brasileiro de Oftalmologia, Publisher. 2:351-355 (1980).
Cunha-Vaz JG. Diabetic retinopathy: Human and experimental studies. 111-124. PubMed
Cunha-Vaz JG. Part 2, Chapter 26, What the future holds for ocular fluorophotometry? Ophthalmology Today, p. 173.
Cunha-Vaz JG. Pathophysiology of diabetic retinopathy. Br J Ophthalmol 62:351-355 (1978). PubMed
Cunha-Vaz JG. Protocols for the vitreous fluorophotometry examination: A general plan. Graefe’s Arch Clin Exp Ophthalmol 222: 220 (1985).
Cunha-Vaz JG. Studies on the pathophysiology of diabetic retinopathy: the blood-retinal barrier in diabetes. Diabetes 32:20-26 (1983). PubMed
Cunha-Vaz JG. Studies on the permeability of the blood-retinal barrier. Br J Ophthalmol 50:505-516 (1966). PubMed
Cunha-Vaz JG. Studies on the permeability of the blood-retinal barrier. II. Breakdown of the blood-retinal barrier by injury. Br J Ophthalmol 50:454-462 (1966). PubMed
Cunha-Vaz JG. The blood-ocular barriers. International Congress Series 508:14-27 (1978).
Cunha-Vaz JG. The blood-ocular barriers. Invest Ophthalmol Vis Sci 17:1037-1039 (1978).
Cunha-Vaz JG. The blood-retinal barriers. Doc Ophthalmol 41:287-328 (1976). PubMed
Cunha-Vaz JG. Vitreous fluorophotometry recordings in posterior segments disease. Graefe’s Arch Clin Exp Ophthalmol 222:241-247 (1985). PubMed
Cunha-Vaz JG. Vitreous fluorophotometry studies in diabetes. Dev Ophthalmol 2:214-221 (1981). PubMed
Cunha-Vaz JG. What the Future Holds for Ocular Fluorophotometry? In Book: Ophthalmology Today p. 173.
Cunha-Vaz JG, De Lima JJP. Estimation of human retinal blood flow by slit lamp fluorophotometry. II. Results and discussion. Ircs Med Sci Biomed Techn (England) 3:11 (1975).
Cunha-Vaz JG, Faria de Abreu JR, Campos AJ. Early breakdown of the blood-retinal barrier in diabetics. Br J Ophthalmol 59:649-656 (1975). PubMed
Cunha-Vaz JG, Faria de Abreu JR, Teixeira R. The role of the retinal barrier. Excerpta Medica I.C.S. (Netherlands) 1:605-607 (1979).
Cunha-Vaz JG, Fonseca JR, Faria de Abreu JR, Lima JJP. Studies on retinal blood flow II. Diabetic retinopathy. Arch Ophthalmol 96:809-811 (1978). PubMed
Cunha-Vaz JG, Fonseca JR, Faria de Abreu JR, Ruas MA. A follow up study by vitreous fluorophotometry of early retinal involvement in diabetes. Am J Ophthalmol 86:467-473 (1978). PubMed
Cunha-Vaz JG, Fonseca JR, Faria de Abreu JR, Ruas MA. Detection of early retinal changes in diabetes by vitreous fluorophotometry. Diabetes 28:16-19 (1979). PubMed
Cunha-Vaz JG, Fonseca JR, Faria de Abreu JR. Vitreous fluorophotometry and retinal blood flow studies in diabetic retinopathy. Meth Pediat Ophthalmol 3:259-261 (1979).
Cunha-Vaz JG, Fonseca JR, Faria de Abreu JR. Vitreous fluorophotometry and retinal blood flow studies in proliferative retinopathy. Albrecht V. Graefe’s Arch Klin Exp Ophthal 207:71-76 (1978). PubMed
Cunha-Vaz JG, Fonseca JR, Hagenouw JRB. Treatment of early diabetic retinopathy with cyclandelate. Br J Ophthalmol 61:399-404 (1977). PubMed
Cunha-Vaz JG, Goldberg MF, Vylantas C, Noth J. Early detection of retinal involvement in diabetes by vitreous fluorophotometry. Ophthalmology 86:264-275 (1979). PubMed
Cunha-Vaz JG, Gray JR, Zeimer R, Mota MC, Ishimoto BM, Blair N, Leite E. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry. Diabetes 34:53-59 (1985). PubMed
Cunha-Vaz JG, Lima JP, Fonseca JR. (New methods of functional examination of the retina.) Exper Ophthalmol (Portugal) 4:1-7 (1978).
Cunha-Vaz JG, Lima JP. Studies on retinal blood flow. Part I: Estimation of human retinal blood flow by slit lamp fluorophotometry. Arch Ophthalmol 96:893-897 (1978). PubMed
Cunha-Vaz J, Lobo C, Sousa JC, Oliveiros B, Leite E, de Abreu JR. Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study. Graefes Arch Clin Exp Ophthalmol 236:264-8 (1998). PubMed
Cunha-Vaz JG, Mahlberg PA, Tessler HH. La fluorophotometrie du vitre dans le pars planite. Bull Mem Soc Fr Ophthalmol 94:345-349 (1982). PubMed
Cunha-Vaz JG, Maurice DM. Fluorescein dynamics in the eye. Doc Ophthalmol 26:61-72 (1969). PubMed
Cunha-Vaz JG, Maurice DM. The active transport of fluorescein by the retinal vessels and the retina. J Physiol 191:467-486 (1967). PubMed
Cunha-Vaz JG, Mota C, Leite E, Faria de Abreu JR, Ruas MA. Effect of aldose-reductase inhibitors on the blood-retinal barrier in early diabetic retinopathy. Diabetes 34:109A (1985). PubMed
Cunha-Vaz JG, Mota CC, Leite EC, Faria de Abreu JR, Ruas MA. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy. Diabetes 35:574-578 (1986). PubMed
Cunha-Vaz JG, Mota CC, Leite EC, Faria de Abreu JR, Ruas MA. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy. Arch Ophthalmol 103:1307-1311 (1985). PubMed
Cunha-Vaz JG, Osborne NN, Chader GJ. Vitreous fluorophotometry In: Progress In Retinal Research (N. N. Osborne, G. J. Chader eds). Pergamon Press (Oxford) pp. 89-114 (1985).
Cunha-Vaz JG, Rosenthal I, Weiss E, Blair N. Vitreous fluorophotometry and metabolic control in insulin-dependent juvenile-onset diabetic patients. Proceed 24th International Congress of Ophthalmology: 730-732 (1983).
Cunha-Vaz JG, Travassos A. Breakdown of the blood-retinal barriers and cystoid macular edema. Surv Ophthalmol Suppl: 485-492 (1984). PubMed
Cunha-Vaz JG, Tso MOM. The alteration of blood-retinal barriers in retinal disease and vitreous fluorophotometry. American Academy of Ophthalmology, Course 279 (1981).
Cunha-Vaz JG, Zeimer R, Mahlberg P, Tessler H. Vitreous fluorophotometry studies in pars planitis. In: Retinal Diseases (S. I. Ryan, A. K. Dawson, H. L. Little eds). Grune and Stratton (Orlando) pp. 53-57 (1984).
Cunha-Vaz JG, Zeimer R, Wong WP, Kiani R. Kinetic vitreous fluorophotometry in normals and noninsulin-dependent diabetics. Ophthalmology 89:751-756 (1982). PubMed
Cunha-Vaz JG, Zeimer R. Configuration of the normal vitreous fluorophotometry. Graefe’s Arch Clin Exp Ophthalmol 222:234-236 (1985).
Dacey DM. Dopamine-accumulating retinal neurons revealed by in vitro fluorescence display a unique morphology. Science 240:1196-1198 (1988). PubMed
Dalgaard P, Barker VA, Lund-Anderson H. Vitreous fluorophotometry: Mathematical analysis of the effect of peripheral leakage on axial scans. Invest Ophthalmol Vis Sci 30:1522-1526 (1989). PubMed
De Gregorio F, Taverniti L, Matteocci G, Sedran L, Repossi R. Activity of bovine 8th factor on permeability of blood-retinal barrier of diabetic patients: fluorophotometric study. Boll Ocul 72:265- (1993).
De Groot V, Hubert M, Van Best JA, Engelen S, Van Aelst S, Tassignon MJ. Lack of fluorophotometric evidence of aqueous-vitreous barrier disruption after posterior capsulorhexis. J Cataract Refract Surg 29(12):2330-8 (2003). PubMed
Delori FC, Busell SE, Yoshida A, Mcmell JW. Vitreous fluorophotometry in diabetics: Study of artifactual contributions. Graefe’s Arch Clin Exp Ophthalmol 222:215-218 (1985). PubMed
Delori FC, Castany MA, Webb RH. Fluorescence characteristics of sodium fluorescein in plasma and whole blood. Exp Eye Res 27:417-425 (1978). PubMed
Dickmann LJ, Yip V, Li C, Abundes J Jr, Maia M, Young C, Stainton S, Hass PE, Joseph SB, Prabhu S, Boswell CA. Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein Therapeutics. Invest Ophthalmol Vis Sci. 56(11):6991-9 (2015). PubMed
Do Carmo A, Ramos P, Reis A, Proen R, Cunha-vaz JG. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. Exp Eye Res 67:569-75 (1998). PubMed
Doft B, Kingsley LA, Orchard TJ, Kuller L, Drash A, Becker D. The association between long-term diabetic control & early retinopathy. Ophthalmology 91:763-769 (1984). PubMed
Domoslawski M, Skopinski P, Trippenbach H. [Fluorophotometric study of juvenile insulin-dependent diabetic patients] Klin Oczna 100(6):369-71 (1998). Polish. PubMed
Dutton JJ, Krupin T, Waltman SR, Kolomas BA, Becker B. Fluorophotometry and the blood-ocular barrier in experimental systemic hypertension. Arch Ophthalmol 98:731-733 (1980). PubMed
Eberli B, Riva CE, Feke GT. Mean circulation time of fluorescein in retinal vascular segments. Arch Ophthalmol 97:146-148 (1979). PubMed
Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80(2):249-58 (2005). PubMed
Enea NA, Hollis TM, Kern JA, Gardner TW. Histamine Hl receptors mediate increased blood-retinal barrier permeability in experimental diabetes. Ophthalmology 107:270-274 (1989). PubMed
Ennis SR, Vine AK, Kisly AM, Goldstein GW, Betz AL. Blood-retinal barrier in diabetes (comparison of sucrose and fluorescein). Draft.
Enzmann V, Ruprecht KW. Complications of fluorescence angiography of the retina. Symptoms, prophylaxis and therapy. Klin Monatsbl Augenheilkd 181:235-239 (1982). PubMed
Erik-Bursell S, Delori F, Yoshida A. Instrument characterization for vitreous fluorophotometry. Curr Eye Res 1:12 (1981). PubMed
Fishman G, Ward L, Rusin M. Vitreous fluorophotometry in patients with Best’s macular dystrophy. Retina 10:102-104 (1990). PubMed
Fishman GA, Cunha-Vaz JG, Salzano T. Vitreous fluorophotometry in patients with retinitis pigmentosa (draft). Arch Ophthalmol 99:1202-1207 (1981). PubMed
Fishman GA, Cunha-Vaz JG, Travassos AC. Vitreous fluorophotometry in patients with fundus flavimaculatus. Arch Ophthalmol 100:1086-1088 (1982). PubMed
Fishman GA, Cunha-Vaz JG. Carriers of X-linked recessive retinitis pigmentosa: Investigation by vitreous fluorophotometry. Int Ophthalmol 4:37-44 (1981). PubMed
Fishman GA, Rhee AJ, Blair NP. Blood-retinal barrier function in patients with cone or cone-rod dystrophy. Arch Ophthalmol 104:545-548 (1986). PubMed
Frank RN. The mechanism of blood-retinal barrier breakdown in diabetes. Arch Ophthalmol 103:1303-1304 (1985). PubMed
Frau E, Gregoire-Cassoux N, Offret M, Labetoulle M, Nodarian M, Lautier-Frau M, Offret H. [Rupture of the hemato-ocular barrier, studied by fluorophotometry, in uveal melanoma patients. Preliminary results] J Fr Ophtalmol 21:409-13. (1998). (French). PubMed
Ghate D, Brooks W, McCarey BE, Edelhauser HF. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci 48:2230-7 (2007). PubMed
Gieser DK, Fishman GA, Cunha-Vaz JG. X-linked recessive retinitis pigmentosa and vitreous fluorophotometry a study of female heterozygotes. Arch Ophthalmol 98:307-310 (1980). PubMed
Golshani MR, Khoobehi B, Peyman GA. Calcein: A new dye for evaluation of the blood-retinal barrier by fluorophotometry. Int Ophthalmol 17:349- (1993). PubMed
Golshani MR, Khoobehi B, Peyman GA, Aras C. Calcein fluorophotometry in streptozocin-induced diabetic rats. Ophthalmic Surg 25:526- (1994). PubMed
Goss DA. Vitreous fluorophotometry – a new technique for the early detection of diabetic retinopathy. Optometric Monthly pp 93-95 (1980).
Gray JR, Mosier MA, Ishimoto BM. Optimized protocol for Fluorotron Master. Graefe’s Arch Clin Exp Ophthalmol 222:225-229 (1985). PubMed
Gregor Z, Ryan SJ. Blood-retinal barrier after blunt trauma to the eye. Graefe’s Arch Clin Exp Ophthalmol 219: 205-208 (1982). PubMed
Grimes PA, Stone RA, Laties AM, et al. Carboxyfluorescein: A probe of the blood-ocular barriers with lower membrane permeability than fluorescein. Arch Ophthalmol 100: 635-639 (1982). PubMed
Grimes PA, Stone RA. Interaction of fluorescent organic anion dyes with cells of the blood-retinal barrier after intravitreal injection. Invest Ophthalmol Vis Sci 26(Suppl):337 (1985).
Hanyuda T, Numaga T. Kishi S. Yoneya S. (Vitreous fluorophotometry in experimental pigment epitheliopathy.) Acta Soc Ophthalmol Jpn 89:503-511 (1985). PubMed
Herman DC, McLaren JW, McPhee T. The effects of probenecid on the kinetics of fluorescein. Summary of Information for Review of Research Involving Human Subjects.
Hochheimer BF. A dye for experimental choroidal angiography. Exp Eye Res 29:141-143 (1979). PubMed
Hodge JV, Clemett RS. Improved method for fluorescence angiography of the retina. Am J Ophthalmol 61:1400-1404 (1966). PubMed
Howard-Williams JR, Siegel MJ, Podos SM, Brown V. Alteration of the blood-retinal barrier by dipyridamole. Arch Ophthalmol 104:488-490 (1986). PubMed
Hunter JE. Oral fluorography in a retinal pigment epithelial detachment. Am J Optom Physiol Opt 59:926-928 (1982). PubMed
Ichikawa H, Ando F, Yasuma T, Goto S. (Studies on disturbances in the blood retinal barrier 1. A trial to measure the fluorescein concentration in the vitreous.) Acta Soc Ophthalmol Jpn 84:88-96 (1980). PubMed
Ishiko S, Yoshida A, Kitaya N, Abiko T, Mori F, Kado M, Takahashi M, Saito K. Fluorophotometry of the animal eye. J Jpn Ophthalmol Soc 100:257- (1996). PubMed
Ishiko S, Yoshida A, Mori F, Abiko T, Kitaya N, Kojima M, Saito K. Early ocular changes in a tree shrew model of diabetes. Nippon Ganka Gakkai Zasshi 101:19-23 (1997). PubMed
Ishimoto BM, Zeimer RC, Cunha-Vaz JG, Rusin MM. Data analysis and presentation in vitreous fluorophotometry. Invest Ophthalmol Vis Sci 26(Suppl):215 (1985).
Iwase T, Oveson BC, Hashida N, Lima e Silva R, Shen J, Krauss AH, Gale DC, Adamson P, Campochiaro PA. Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit. Invest Ophthalmol Vis Sci 54(1):503-11 (2013). PubMed
Jaccoma EH, Conway BP, Campochiaro PA. Cryotherapy causes extensive breakdown of the blood-retinal barrier. A comparison with argon laser photocoagulation. Arch Ophthalmol 103:1728-1730 (1985). PubMed
Jackson WE, Chase HP, Garg SK, Bartlett DA, Hoops S, Harris S, Marshall G, Ishimoto BM. Vitreous fluorophotometry in insulin-dependent diabetes mellitus. Arch Ophthalmol 108:1733-1735 (1990). PubMed
Jampol LM, Noth J. Further studies of the ipsilateral and contralateral responses to topical nitrogen mustard. Exp Eye Res 28:591-600 (1979). PubMed
Jampol LM, Setogawa T, Rednam KRV, Tso MOM. Talc retinopathy in primates maca-mulatta a model of ischemic retinopathy 1. Clinical studies. Arch Ophthalmol 99:1273-1280 (1981). PubMed
Jampol LM, White S, Cunha-Vaz JG. Vitreous fluorophotometry in patients with hypertension. Arch Ophthalmol 101:888-890 (1983). PubMed
Joccoma EH, Conway BP, Campochiaro PA. Cryotherapy causes extensive breakdown of the blood retina barrier. Invest Ophthalmol Vis Sci 26(Suppl):31 (1985).
Jones CW, Cunha-Vaz JG, Rusin MM. Vitreous fluorophotometry in the alloxan- and streptozocin-treated rat. Arch Ophthalmol 100:1141-1145 (1982). PubMed
Jones CW, Cunha-Vaz JG, Sweig KO, Stein M. Kinetic vitreous fluorophotometry in experimental diabetes. Arch Ophthalmol 97:1941-1943 (1979). PubMed
Jones DP, Smith AT, Sturrock GD, Wright P. Ophthalmic fluorophotometry an improved slit lamp fluorophotometer. Med Biol Eng Comput 17:365-370 (1979). PubMed
Junnuthula V, Sadeghi Boroujeni A, Cao S, Tavakoli S, Ridolfo R, Toropainen E, Ruponen M, van Hest JCM, Urtti A. Intravitreal Polymeric Nanocarriers with Long Ocular Retention and Targeted Delivery to the Retina and Optic Nerve Head Region. Pharmaceutics 13:445 (2021). PubMed
Kadamoto H. Vitreous fluorophotometry after vortex vein occlusion in rabbit eyes. Acta Soc Ophthalmol Jpn 93:276 (1989).
Kato M, Ando F. Studies on the blood-retinal barrier after cryoretinopexy with vitreous fluorophotometry. Nasoya J Med Sci 46:79-86 (1984). PubMed
Kawasaki K. [Preretinopathic changes in the oscillatory potential in diabetic retina: interpretation and significance] Nippon Ganka Gakkai Zasshi 102(12):813-36 (1998). Review. Japanese. PubMed
Kayazawa F, Miyake K. Ocular fluorophotometry in patients with essential hypertension. Arch Ophthalmol 102:1169-1170 (1984). PubMed
Kayazawa F, Miyatani H, Umetani K, Itoi M. A biotechnical consideration on smoke-stack dye leakage in central serous retinopathy. Acta Soc Ophthalmol Jpn 86:1957-1961 (1982). PubMed
Kayazawa F, Tamura S, Tsuji T, Matsuda T, Kuwayama W, Machida T. (The influence of physiochemical factors on fluorescence of fluorescein sodium, and vitreous fluorophotometry of normal subjects) Nippon Ganka Gakkai Zasshi (Japan) 87:319-326 (1983). PubMed
Kayazawa F, Tamura S, Tsuji T, Matsuda T, Kuwayama W, Machida T. (The influence of the technique of measurement on vitreous fluorophotometry) Nippon Ganka Gakkai Zasshi (Japan) 87:321- (1983). PubMed
Kayazawa F, Tamura S, Tsuji T, Matusda T, Kuwayama W, Machida T. (Influence of aging on vitreous fluorophotometry) Nippon Ganka Gakkai Zasshi (Japan) 87:380-383 (1983). PubMed
Kayazawa F, Tsuji T, Matsuda T, Kuwayama W, Machida T. (Vitreous fluorophotometry in diabetes with normal fundi) Nippon Ganka Gakkai Zasshi (Japan) 87:595-601 (1983). PubMed
Kayazawa F, Tsuji T, Matsuda T, Tamura S, Machida T, Kuwayama W. The influence of physiochemical factors on fluorescence of fluorescein sodium and vitreous fluorophotometry of normal subjects. Acta Soc Ophthalmol Jpn 87:312-318 (1983). PubMed
Kayazawa F. Ocular fluorophotometry in diabetic patients without apparent retinopathy. Ann Ophthalmol 16:221-225 (1984) PubMed.
Kayazawa F. Vitreous fluorophotometry in diabetic patients without apparent retinopathy. J Jpn Diabet Soc (Japan) 26:1019-1024 (1983).
Kernell A. The use of vitreous fluorophotometry for early detection of retinopathy in juvenile diabetics. Klinische Padiatrie 195:379-379 (1983).
Kernell A, Arnquist H. Effect of insulin treatment on the blood-retinal barrier in rats with streptozocin-induced diabetes. Arch Ophthalmol 101:968-970 (1983). PubMed
Kernell A, Dahlkvist H, Arnquiust H, Ludvigsson J. Influence of metabolic control on the blood-retinal barrier in streptozocin diabetic rats. Graefe’s Arch Clin Exp Ophthalmol 222:179-181 (1985).
Kernell A, Larsson Y, Ludvigsson J, Tenland T. Vitreous fluorophotometry in juvenile diabetes. Acta Endocrinol 238:67-74 (1980). PubMed
Kernell A, Larsson Y, Ludvigsson J, Tenland T. Vitreous fluorophotometry in the early diagnosis of retinopathy in juvenile diabetics. Acta Ophthalmol (Denmark) 58:861-862 (1980).
Kernell A, Ludvigsson J. Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations, HLA-DR types, and metabolic control. Graefe’s Arch Clin Exp Ophthalmol 222:250-253 (1985). PubMed
Kernell A, Ludvigsson J, Finnstrom K. Vitreous Fluorophotometry in Juvenile Diabetics With and Without Retinopathy in Relation to Metabolic Control. Acta Ophthal 68:415- (1990). PubMed
King GL, Johnson SM. A cell culture model of retinal capillary-demonstration of endothelial cells’ role in capillary permeability to fluorescein. Invest Ophthalmol Vis Sci 26(Suppl):154 (1985).
Kinjo M, Miyazato A, Miyazato M, Flukuda M. Vitreous fluorophotometry in diabetic retinopathy. Jpn J Clin Ophthalmol 42:93-96 (1988).
Kitano S, Nagataki S. Fluorescein monoglucuronide in the rabbit vitreous. Invest Ophthalmol Vis Sci 26(Suppl):107 (1985).
Kitano S, Nagataki S. Transport of fluorescein monoglucuronide out of the vitreous. Invest Ophthalmol Vis Sci 27:998-1001 (1986). PubMed
Kitaya N, Ishiko S, Abiko T, Mori F, Kagokawa H, Kojima M, Saito K, Yoshida A. Changes in blood-retinal barrier permeability in form deprivation myopia in tree shrews. Vision Res 40(17):2369-77 (2000). PubMed
Kitaya N, Mori F, Hikichi T, Takahashi J, Yoshida A. Effects of latanoprost on blood-retinal barrier permeability in rabbits. Ophthalmic Res 35(5):276-80 (2003). PubMed
Kizhakkethara I, Li X, el-Sayed S, Khoobehi B, Moshfeghi DM, Rahimy M, Peyman GA. Noninvasive monitoring of intraocular pharmacokinetics of daunorubicin using fluorophotometry. Int Ophthalmol 19(6):363-7 (1995-1996). PubMed
Kjaergaard JJ, Fabrin K, Jensen S, Ditzel J. Vitreous fluorophotometry and hemoglobin AIC in non-proliferative retinopathy. Acta Endocrinol 238:67-74 (1980). PubMed
Kjaergaard JJ, Ohrt V. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy. International Journal of Microcirculation-Clinical and Experimental 2:207-213 (1983). PubMed
Kjaergaard JJ. Fluorophotometric studies of twenty-nine healthy subjects. Graefe’s Arch Clin Exp Ophthalmol 222:267-268 (1985).
Kjaergaard JJ. Ocular fluorophotometry in normal subjects. International Journal of Microcirculation-Clinical and Experimental 2:199-205 (1983). PubMed
Klein R, Engerman RL, Ernest JT. Fluorophotometry: II. Streptozocin-treated guinea pigs. Arch Ophthalmol 98:2233-2234 (1980). PubMed
Klein R, Wallow IIH, Ernest T. Fluorophotometry: III. Streptozin-treated rats & rats with pancreatectomy. Arch Ophthalmol 98:2235-2237 (1980). PubMed
Knudsen LL, Olsen T, Nielsen Kudsk F. Anterior chamber fluorescein kinetics compared with vitreous kinetics in normal subjects. Acta Ophthalmol Scand 76:561-567 (1998). PubMed
Knudsen LL, Olsen T, Nielsen-Kudsk F. Fluorometric evaluation of panretinal photocoagulation in diabetic subjects. Acta Ophthalmol Scand 75:393-397 (1997). PubMed
Knudsen LL, Olsen T, Nielsen-Kudsk F. Long-term kinetic vitreous fluorophotometry. Acta Ophthalmol 70:561- (1992). PubMed
Knudsen LL, Olsen T, Nielsen-Kudsk F. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects. Acta Ophthalmol 70:570- (1992). PubMed
Knudsen LL, Nielsen Kudsk F. Anterior chamber and vitreous fluorescein kinetics in normal and diabetic subjects. Acta Ophthalmol Scand 76:396-400 (1998). PubMed
Knudsen LL, Nielsen-Kudsk F. Can vitreous fluorophotometry predict the necessity for photocoagulation? A 5-year follow-up study. Acta Ophthalmol Scand 78(4):390-5 (2000). PubMed
Kohner EM, Alderson AR. Vitreous fluorophotometry. Trans Ophthalmol Soc U.K. 101:445-449 (1981). PubMed
Kooijman CA, Van Den Berg W, Blanksma LJ, Siertsema JV. Quantative determination of fluorescein in the anterior chamber and vitreous body. Doc Ophthalmol (Netherlands) 52:333-337 (1982). PubMed
Korte GE, Bellhorn RW, Burns MS. Ultrastructure of blood-retinal barrier permeability in rat phototoxic retinopathy. Invest Ophthalmol Vis Sci 24:962-971 (1983). PubMed
Korte GE, Bellhorn RW, Burns MS. Urethane-induced rat retinopathy. Plasticity of the blood-retinal barrier in disease. Invest Ophthalmol Vis Sci 25:1027-1034 (1984). PubMed
Koyano S, Eguchi S, Araie M. Transfer of fluorescein and fluorescein glucuronide across the isolated rabbit rabbit retinal pigment epithelium (RPE)-choroid. Invest Ophthalmol Vis Sci 29(Suppl):20 (1988).
Kritzinger EE, Bellhorn RW. Permeability of blood-retinal barriers in urethane-induced rat retinopathy: A fluorescein angiographic, vitreous fluorophotometric, and fluorescence microscopic study. Br J Ophthalmol 66:630-635 (1982). PubMed
Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L, Larsen J. The blood-retinal barrier permeability in diabetic patients. Acta Ophthalmol (Denmark) 59:689-694 (1981). PubMed
Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L. Blood-retinal barrier permeability versus diabetes duration and retinal morphology. Acta Ophthalmol 65:686 (1987). PubMed
Krogsaa B, Lund-Anderson H, Parving HH, Bjaeldager P. The blood-retinal barrier permeability in essential hypertension. Acta Ophthalmol 61:541-544 (1983). PubMed
Krupin T, Waltman SR, Becker B. Vitreous fluorophotometry in diabetes mellitus. Ophthalmology 86:137-141 (1979). PubMed
Krupin T, Waltman SR, Oestrich C, Santiago J, Ratzan S, Kilo C, Becker B. Vitreous fluorophotometry in juvenile-onset diabetes mellitus. Arch Ophthalmol 96:812-814 (1978). PubMed
Krupin T, Waltman SR, Scharp DW, Oestrich C, Feldman SD, Becker B, Ballinger WF, Lacy PE. Ocular fluorophotometry in streptozocin diabetes mellitus in the rat: effect of pancreatic islet isografts. Invest Ophthalmol Vis Sci 18:1185-1190 (1979). PubMed
Krupin T, Waltman SR, Szewczyk P, Koloms B, Farber M, Silverstein B, Becker B. Fluorometric studies on the blood-retinal barrier in experimental animals. Arch Ophthalmol 100:631-634 (1982). PubMed
Krupin T, Waltman SR. Fluorophotometry in juvenile-onset diabetes: Long-term follow-up. Jpn J Ophthalmol 29:139-145 (1985). PubMed
Larsen M, Hommel E, Parving H-H, Lund-Andersen H. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Graefe’s Arch Clin EXp Ophthalmol 228:505-509 (1990). PubMed
Larsen M, Loft S, Hommel R, Lund-Anderson H. Fluorescein and fluorescein monoglucuronide in plasma after intravenous injection of fluorescein. Acta Ophthalmol 66:427-432 (1988). PubMed
Larsen M., Lund-Anderson H. Binding and fluorescence of fluorescein and fluorescein glucuronide in vitreous. Acta Ophthalmol (1988) Submitted.
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1:200-294 (1983). PubMed
Lauritzen T, Frost-Larsen K, Svendsen PA, Larsen HW, Deckert T, Christiansen JS, Parving HH, Binder C, Nerup J, et al. Effect of 6 months of strict metabolic control on eye and kidney function in insulin dependent diabetics with background retinopathy. Lancet 1:121-124 (1982).
Lavenstein B, Milder B, Winkelman JZ, Zappia RJ, Gay AJ. Retinal and choroidal circulation in rabbits: Fluorophotometer measurements in animals with and without carotid artery occlusion. 6:234-248 (1971). PubMed
Lee VK, Hosking BM, Holeniewska J, Kubala EC, Lundh von Leithner P, Gardner PJ, Foxton RH, Shima DT. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Diabetologia 61(11):2422-2432 (2018). PubMed
Leichter S, Collins R, Schreiner M. Computerized axial fluorophotometry (CAF). Diabetes 34:107A (1985).
Leite E, Branco V, Faria de Abreu JR, Rasteiro A. Acquired immunodeficiency syndrome. Experientia Ophthalmol 11:17-22 (1985).
Leite E, Mota MC, Murta J, Faria de Abreu JR. Foveolar avascular area in diabetic patients without retinopathy. Experientia Ophthalmol 11:23-27 (1985).
Li Y, Alhendi AMN, Yeh MC, Elahy M, Santiago FS, Deshpande NP, Wu B, Chan E, Inam S, Prado-Lourenco L, Marchand J, Joyce RD, Wilkinson-White LE, Raftery MJ, Zhu M, Adamson SJ, Barnat F, Viaud-Quentric K, Sockler J, Mackay JP, Chang A, Mitchell P, Marcuccio SM, Khachigian LM. Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB-VCAM-1 axis. Sci Adv 29:6(2020). PubMed
Lobo CL, Bernardes RC, de Abreu JR, Cunha-Vaz JG. One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative retinopathy. Arch Ophthalmol 119(10):1469-74 (2001). PubMed
Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-Vaz JG. Three-year follow-up study of blood-retinal barrier and retinal thickness
alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Arch Ophthalmol 122(2):211-7 (2004). PubMed
Lobo CL, Bernardes RC, Santos FJ, Cunha-Vaz JG. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous. Arch Ophthalmol 117(5):631-7 (1999). PubMed
Lund-Andersen H, Krogsaa B, La Cour M, Larsen J. Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26:698-710 (1985). PubMed
Lund-Andersen H, Krogsaa B, Larsen J. Calculation of the permeability of the blood-retinal barrier to fluorescein. Graefe’s Arch Clin Exp Ophthalmol 222:173-176 (1985). PubMed
Lund-Andersen H, Krogsaa B, Larsen J. Computerized calculation of blood-retinal barrier permeability and vitreous body diffusion coefficient for fluorescein in man. Proceed 24th International Congress of Ophthalmology: 730-732 (1983).
Lund-Andersen H, Larsen M. Microvascular permeability in diabetic patients. Bibl Anat 20:675-678 (1981).
Lund-Anderson H, Larsen M, Dalgaard P, Olsen W. Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients. Graefe’s Arch Clin Exp Ophthalmol 225:173-176 (1987). PubMed
Maeda K, Imai T, Nomura T, Ohta K. (Vitreous fluorophotometry in diseased retinal blood barriers III. Chronic glomerulo nephritis 1.) Jpn J Clin Ophthalmol 35:53-59 (1981).
Mahlberg PA, Cunha-Vaz JG, Tessler HH. Vitreous fluorophotometry in pars planitis. Am J Ophthalmol 95:189-196 (1983). PubMed
Mallick KS, Zeimer RC, Fishman GA. Transport of fluorescein in the ocular posterior segment in retinitis pigmentosa. Arch Ophthalmol 102:691-696 (1984). PubMed
Marmor MF, Negi A, Maurice DM. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res 40:687-696 (1985). PubMed
Marmor MF. Barriers to fluorescein and protein movement. Jpn J Ophthalmol 29:131-138 (1985). PubMed
Maurice DM. The flow of water between the aqueous and vitreous compartments in the rabbit eye. Am J Physiol 21:F104-108 (1987). PubMed
Maurice DM. Iontophoresis of fluorescein into the posterior segment of the rabbit eye. Ophthalmology 93:128-132 (1986). PubMed
Maurice DM. Theory and methodology of vitreous fluorophotometry. Jpn J Ophthalmol 29:119-130 (1985). PubMed
Maurice DM. Vitreous fluorophotometry. Japan lecture. PubMed
McCullough PC, Koester CJ, Campbell CJ. An evaluation of the clinical role of vitreous fluorophotometry. Tr Am Ophth Soc 81:130-148 (1983). PubMed
McLaren JW, Brubaker RF. Measurement of fluorescein and fluorescein glucuronide in the living human eye. Invest Ophthalmol Vis Sci 27:966-974 (1986). PubMed
Merin SM, Blair NP, Tso OM. Vitreous fluorophotometry in patients with senile macular degeneration. Invest Ophthalmol Vis Sci 28:756-759 (1987). PubMed
Miyake K, Asakura M. Intraocular surgeries and blood retinal barrier. Folia Ophthalmol Jpn 36:1190-1194 (1982).
Miyake K, Goto S, Ota I, Ichikawa H. Vitreous fluorophotometry in patients with cone-red dystrophy. Br J Ophthalmol 68:489-493 (1984). PubMed
Miyake K, Ichihashi S, Shibuya Y, Ota I, Miyake S, Terasaki H. Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia. J Cataract Refract Surg 25(7):891-7 (1999). PubMed
Miyake K, Maeda K, Imai T, et al. Vitreous fluorophotometry in diseased blood retinal barriers. Ill. Chronic glomerulonephritis (Part 1). J Clin Ophthalmol (Japan) 35: 53-59 (1981).
Miyake K. Blood-retinal barrier in eyes with long-standing aphakia with apparently normal fundi. Arch Ophthalmol 100:1437-1439 (1982). PubMed
Miyake K. Vitreous fluorophotometry in aphakic or pseudoaphakic eyes with persistent cystoid macular edema. Jpn J Ophthalmol 29:146-152 (1985). PubMed
Miyake Y, Gto S, Ando F, Ichikawa H. Vitreous fluorophotometry in congenital stationary nightblindness. Arch Ophthalmol 101:574-576 (1983). PubMed
Miyazato A, Uehara M, Kinjo M, Sagae Y, Shinzato K. Vitreous fluorophotometry in diabetic retinopathy. Jpn J Clin Ophthalmol 41:779-783 (1987).
Miyazato A. Vitreous fluorophotometry: fluorophotometric findings of macular lesions in diabetic retinopathy. Acta Soc Ophthalmol Jpn 92:313-317 (1988). PubMed
Moldow B, Sander B, Larsen M, Lund-Andersen H. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci 40(8):1770-5 (1999). PubMed
Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR. Collagen-linked fluorescence is a possible marker for very long-term glycemia in type I diabetes. Diabetes 34:215A (1985).
Morgan CM, Lewis GP, Dolan BJ, Stern WH. Vitreous fluorophotometry localization of retinal breaks in experimental retinal detachment. Invest Ophthalmol Vis Sci 26(Suppl):246 (1985).
Mosier MA, Gray JR, Ishimoto BM. Ocular fluorophotometric analysis. Curr Eye Res 2:699-704 (1983).
Mosier MA, Lopez KH, Noorbaksh KR, Charles MA. Early retinal and renal abnormalities in diabetes. J Diabetes Complications 11:218-224 (1997). PubMed
Mosier MA, Waldeck N, Ascher MS. Assessment of the diabetic retinal-renal syndrome by vitreous fluorophotometry and radioimmunoassay for proteinuria. Diabetes 34:214A (1985).
Nakagawa M, Tanaka M, Miyata T. Evaluation of collagen gel and hyaluronic acid as vitreous substitutes. Ophthalmic Res 29:409-420 (1997). PubMed
Noble MJ, Chens H, Jacobs PM. Oral fluorescein and cystoid macular edema: Detection in aphakic and pseudophakic eyes. Br J Ophthalmol 68:221-224 (1984). PubMed
Noth JM, Vygantas C, Cunha-Vaz JG. Vitreous fluorophotometry evaluation of xenon photocoagulation. Invest Ophthalmol Vis Sci 17:1206-1209 (1978). PubMed
Nuzzi G, Vanelli M, Venturini I, Bonacini M, Boselli E. Vitreous fluorophotometry in juvenile diabetics after oral fluorescein. Arch Ophthalmol 104:1630-1631 (1987).
Nuzzi G, Venturini I, De Gregorio M, Arsenio L, Maraini G. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine. Acta Ophthalmol Scand 75:41-43 (1997). PubMed
Ogura Y, Cunha-Vaz JG, Zeimer RC. Evaluation of vitreous body integrity in retinitis pigmentosa by vitreous fluorophotometry. Arch Ophthalmol 105:517-519 (1987). PubMed
Ogura Y, Takahashi Y, Tsukahara Y, Miki M, Kondo T. (Vitreous fluorophotometry in diabetic retinopathy. (1) Correlation with age, duration of disease, retinopathy and blood glucose level) Nippon Ganka Gakkai Zasshi (Japan) 87:253-258 (1983).PubMed
Ogura Y, Tsukada T, Negi A, Honda Y. Integrity of the blood-ocular barrier after intravitreal gas injection. Retina 9:199-202 (1989). PubMed
Ogura Y, Tsukahara Y, Saito J, Kondo T. Fluorophotometry with carboxyfluorescein. Acta Soc Ophthalmol Jpn 88:230-235 (1984). PubMed
Ohashi K, Kageyama M, Shinomiya K, Fujita-Koyama Y, Hirai SI, Katsuta O, Nakamura M. Spermidine Oxidation-Mediated Degeneration of Retinal Pigment Epithelium in Rats. Oxid Med Cell Longev. 2017:4128061 (2017). PubMed
Ohrloff C, Schalnus R, Rothe R, Spitznas M. Role of the posterior capsule in the aqueous-vitreous barrier in aphakic and pseudophakic eyes. J Cataract Refract Surg 16:198-200 (1990). PubMed
Palestine AG, Brubaker RF. Pharmacokinetics of fluorescein in the vitreous. Invest Ophthalmol Vis Sci 21:542-549 (1981). PubMed
Palestine AG, Brubaker RF. Plasma binding of fluorescein in normal subjects and in diabetic patients. Arch Ophthalmol 100:1160-1161 (1982). PubMed
Panda JJ, Yandrapu S, Kadam RS, Chauhan VS, Kompella UB. Self-assembled phenylalanine-a,ß-dehydrophenylalanine nanotubes for sustained intravitreal delivery of a multi-targeted tyrosine kinase inhibitor. J Control Release. 2013 Sep 25. doi:pii: S0168-3659(13)00804-3. (2013). PubMed
Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci 53(8):4433-41 (2012). PubMed
Patil MA, Kompella UB. Noninvasive monitoring of choroid-retina autofluorescence and intravitreal nanoparticle disposition in Royal College of Surgeon rats of different ages and retinal thinning. J Ocul Pharmacol Ther. 36(6):458-466 (2020). PubMed
Paylor R, Carney M, Cunha-Vaz J, Jampol LM, Goldberg MF. Vitreous fluorophotometry in sickle cell retinopathy. Invest Ophthalmol Vis Sci 26(Suppl):30 (1985).
Pederson JE, Cantrill HL. Experimental retinal detachment. V. Fluid movement through the retinal hole. Arch Ophthalmol 102:136-139 (1984). PubMed
Pederson JE. Experimental retinal detachment IV. Aqueous humor dynamics in rhegmatogenous detachments. Arch Ophthalmol 100:1814-1816 (1982). PubMed
Plehwe WE, Chahal PS, Fallon TJ, Cunningham JR, Neal MJ, Kohner EM. Fluorescein glucuronide does not significantly affect vitreous fluorescence. Ocular Fluorophotometry. Proceeding of the International Society of Ocular Fluorophotometry. Brancato R, Coscas G. eds, pp 19-22, Amsterdam/Milano: Kugler and Ghedini (1987).
Plehwe WE, Chahal PS, Fallon TJ, Cunningham JR, Neal MJ, Kohner EM. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry. Exp Eye Res 44(2):209-15 (1987). PubMed
Plehwe WE, Kohner EM. Vitreous fluorophotometry in vitreous degeneration. Arch Ophthalmol 105:1019-1020 (1987). PubMed
Plehwe WE, Sleightholm MS, Kohner EM. Does vitreous fluorophotometry reflect severity of early diabetic retinopathy? Br J Ophthalmol 73:255 (1989). PubMed
Pogrzebielski A, Lubaszewski W, Starzycka M, Kawecka-Jaszcz K. Fluorophotometric evaluation of blood-retinal barrier permeability in patients with essential hypertension. Ophthalmologica 218(3):180-4 (2004). PubMed
Polunin GS, Kasianova NS. (Fluorophotometry in the clinical aspects of eye diseases.) Vestn Oftalmol :52-57 (1979). PubMed
Prager TC, Chu HH, Garcia CA, Anderson RE, Field JB, Orzeck EA, Comstock JP. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement. Invest Ophthalmol Vis Sci 24:57-65 (1983). PubMed
Prager TC, Chu HH, Garcia CA, Anderson RE. The influence of vitreous change on vitreous fluorophotometry. Arch Ophthalmol 100:594-596 (1982). PubMed
Prager TC, Wilson DJ, Avery GD, et al. Vitreous fluorophotometry: Identification of sources of variability. Invest Ophthalmol Vis Sci 21: 854-864 (1981). PubMed
Pulido JS, Blair NP. The blood-retinal barrier in Berlin’s edema. Retina 7:233-236 (1987). PubMed
Quentel G. Fluorophotometrie du vitre. Explorations des vasculopathies reretiniennes. Bull Mem Soc Fr Ophthalmol 93:383-387 (1981). PubMed
Raines MF. Vitreous fluorophotometry: a review. J R Soc Med 81(7):403-6 (1988). PubMed
Raines MF, Duvall-Young J, Short CD. Fundus changes in mesangiocapillary glomerulonephritis type II: Vitreous fluorophotometry. Br J Ophthalmol 73:907-910 (1989). PubMed
Rhee AJ, Blair NP, Fishman GA, Rusin MM. Fluorescein transport in subgroups of cone-rod dystrophy. Invest Ophthalmol Vis Sci 26(Suppl):127 (1985).
Ring K, Larsen M, Dalgaard P, Lund-Andersen H. Fluorophotometric evaluation of ocular barriers and of the vitreous body in the aphakic eye. Acta Ophthalmol 182 (Suppl) 28:160 (1987). PubMed
Rispoli E, Di Cio A, Catarinelli G, Luchetti P, Torella M, Zorzin LR, Pivetti Pezzi P. Electrophysiological and fluorophotometric study in patients treated with hydroxychloroquine. Boll Ocul 72:561- (1993).
Riva CE, Feke Gt, Ben-Sira I. Fluorescein dye-dilution technique and retinal circulation. Am J Physiol 234:31-322 (1978). PubMed
Riva CE, Roberts WP, Mcmeel JW, Ben-Sira 1. Anterior venous mean circulation time in the human retina. The Hague (Netherlands) :113-116 (1976).
Rodman HM, Waltman SR, Krupin T, Lee AT, Frank KE, Matthews LW. Quantitative vitreous fluorophotometry in insulin-treated cystic-fibrosis patients. Diabetes 32: 505-508 (1983). PubMed
Ross S, Arffa R, Miller D, Wiss JN, Ransil BJ. Vitreous variation in vitreous fluorophotometry. Ann Ophthalmol 14:245-249 (1982). PubMed
Roy MS, Bonner RF, Bungay PM, Podgor MJ, Collier B. Posterior vitreous fluorophotometry in normal subjects. Arch Ophthalmol 104:1004-1008 (1986). PubMed
Roy MS, Bungay P, Bonner RF. Posterior vitreous fluorophotometry: II Comparison of diabetic patients and controls with the use of a new analysis procedure. Arch Ophthalmol 107:1328- (1989). PubMed
Roy MS, Podgor MJ, Bungay P, Grunberger G, Carl J, Ellis D. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy. Retina 7:170-176 (1987). PubMed
Rusin MM, Blair NP, Evans MA, Lesar TS, Zeimer RC. Pharmacokinetics of fluorescein and fluorescein glucoronide in the plasma after oral fluorescein. Invest Ophthalmol Vis Sci 26(Suppl):30 (1985).
Rusin MM, Fishman GA, Larson JA, Gilbert LD. Vitreous fluorophotometry in carriers of choroideremia and X-linked retinitis pigmentosa. Arch Ophthalmol 107:209-212 (1989). PubMed
Sadeghi A, Puranen J, Ruponen M, Valtari A, Subrizi A, Ranta VP, Toropainen E, Urtti A. Pharmacokinetics of intravitreal macromolecules: Scaling between rats and rabbits. Eur J Pharm Sci 159:105720 (2021). PubMed
Sadeghi A, Ruponen M, Puranen J, Cao S, Ridolfo R, Tavakoli S, Toropainen E, Lajunen T, Ranta VP, van Hest J, Urtti A. Imaging, quantitation and kinetic modelling of intravitreal nanomaterials. Int J Pharm 621:121800 (2022). PubMed
Sakurai E, Ozeki H, Kunou N, Ogura Y. Effect of particle size of polymeric nanospheres on intravitreal kinetics. Ophthalmic Res 33(1):31-6 (2001). PubMed
Sander B, Larsen M, Engler C, Strom C, Moldow B, Larsen N, Lund-Andersen H. Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol86(3):316-20 (2002). PubMed
Sander B, Larsen M, Moldow B, Lund-Andersen H. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 42(2):433-8 (2001). PubMed
Scharp D, Krupin T, Waltman S, et al. Relationship of abnormal insulin release to fluorophotometry in experimental diabetes.
Sergeys J, Etienne I, Van Hove I, Lefevere E, Stalmans I, Feyen JHM, Moons L, Van Bergen T. Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses. Invest Ophthalmol Vis Sci 60:807-822 (2019). PubMed
Seto C, Araie M, Takase M. Study of fluorescein glucuronide 2. A comparative ocular kinetic study of fluorescein and fluorescein glucuronide. Graefe’s Arch Clin Exp Ophthalmol 224:113-117 (1986). PubMed
Shinowara NL, Grimes PA, Rapoport SI, Laties AM. Acidosis alters fluorescein permeability: Differential tracer penetration through pigment epithelium. Arch Ophthalmol 101:1771-1774 (1983). PubMed
Shiraki K, Burns MS, Bellhorn RW. Abnormal vessel patterns in phototoxic rat retinopathy studied by vascular replicas. Curr Eye Res 2:545-551 (1982). PubMed
Smith RT, Koester CJ, Campbell CJ. Vitreous fluorophotometer data analysis by deconvolution. Invest Ophthalmol Vis Sci 27:406-414 (1986). PubMed
Smith RT, Lee CM, Charles HC, Farber M, Cunha-Vaz JG. Quanitification of diabetic macular edema. Arch Ophthalmol 105:218-222 (1987). PubMed
Smith SS, Ashburn FS, Pilkerton AR, Recant L. Vitreous fluorophotometry in three models of experimental diabetes mellitus. Retina 2:121-125 (1982). PubMed
Stiasny B, Zirm M, Gottinser W. Induced ocular hypertension: Experimental investigations on rabbit eyes. Klin Monatsbl Augenheilkd 181:100-102 (1982). PubMed
Stur M, Reitner A, Irsigler K The correlation of the results of vitreous fluorophotometry and fluorescein angiography in nonproliferative diabetic retinopathy Retina 8:50-54 (1988). PubMed
Szymanski A, Gierek-Lapinska A, Koziak M, Gierek-Kalicka A. Axial and para-axial fluorophotometry in glaucoma simplex. Int Ophthalmol 16:283- (1992). PubMed
Taguchi H, Ogura Y, Takanashi T, Hashizoe M, Honda Y. Fluorophotometric detection of intravitreal peroxides after panretinal laser photocoagulation. Invest Ophthalmol Vis Sci 39:358-363 (1998). PubMed
Taguchi H, Ogura Y, Takanashi T, Hashizoe M, Honda Y. In vivo quantitation of peroxides in the vitreous humor by fluorophotometry. Invest Ophthalmol Vis Sci 37:1444-1450 (1996). PubMed
Takahashi J, Hikichi T, Mori F, Kawahara A, Yoshida A, Peterson WM. Effect of nucleotide P2Y2 receptor agonists on outward active transport of fluorescein across normal blood-retina barrier in rabbit. Exp Eye Res 78(1):103-8 (2004). PubMed
Takahashi J, Mori F, Hikichi T, Yoshida A. Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous flyorophotometry. Curr Eye Res 23(3):166-70 (2001). PubMed
Takanashi T, Ogura Y, Taguchi H, Hashizoe M, Honda Y. Fluorophotometric quantitation of oxidative stress in the retina in vivo. Invest Ophthalmol Vis Sci 38:2721-2728 (1997). PubMed
Takeda M, Mori F, Yoshida A, Takamiya A, Nakagomi S, Sato E, Kiyama H. Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats. Diabetologia 44(8):1043-50 (2001). PubMed
Tamai M, Mizuno K. Electroretinogram changes after fluorescein injection: a new method to evaluate blood-retinal barrier dysfunction. Invest Ophthalmol Vis Sci 20:272-276 (1981). PubMed
Tan LE, Orilla W, Hughes PM, Tsai S, Burke JA, Wilson CG. Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein,
fluorescein dextran, and fluorescent microparticles. Invest Ophthalmol Vis Sci 52(2):1111-8 (2011). PubMed
Tom WW, Dotterrer RM, Villalba M. Sepsis, capillary-permeability and steroids – evaluated by vitreous fluorophotometry. Critical Care Medicine 11:234-234 (1983).
Tso MOM, Cunha-Vaz JG, Shih CY, Jones CW. Clinicopathologic study of blood retinal barrier in experimental diabetes mellitus. Arch Ophthalmol 98:2032-2040 (1980). PubMed
Tsuboi S. Fluid movement across the blood-retinal barrier: A review of studies by vitreous fluorophotometry. Jpn J Ophthalmol 34:133- (1990). PubMed
Tsuboi S. Fluorophotometry: III. Vitreous Fluorophotometry. Folia Ophthalmol Jpn 41:1465- (1990).
Tsuboi S, Fujimoto T, Uchihori Y, Emi K, Iizuka S, Kishida K, Manabe R. Measurement of retinal permeabilitiy to sodium fluorescein in vitro. Invest Ophthalmol Vis Sci 25:1146-1150 (1984). PubMed
Tsuboi S, Pederson JE. Acetazolamide effect on the inward permeability of the blood-retinal barrier to carboxyfluorescein. Invest Ophthalmol Vis Sci 28:92-95 (1987). PubMed
Tsuboi S, Pederson JE. Permeability of the blood-retinal barrier to carboxyfluorescein in eyes with rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 28:96-100 (1987). PubMed
Tsuboi S, Pederson JE. Experimental retinal detachment: Effect of acetazolamide on vitreous fluorescein disappearance. Invest Ophthalmol Vis Sci 26(Suppl):30 (1985). PubMed
Tsukahara Y, Maurice, D.M. Local pressure effects on vitreous kinetics. Exp Eye Res 60:563-574 (1995). PubMed
Tyagi P, Kadam RS, Kompella UB. Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry. PLoS One 7(10)(2012). PubMed
Tyagi P, Barros M, Stansbury JW, Kompella UB. Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab. Mol Pharm: 2858-67 (2013). PubMed
van Best JA, Oosterhuis JA, Vandelft JF. A practical method for determining the course of unbound fluorescein concentration in plasma during fluorophotometry. Ophthalmic Res 16:217 (1984).
van Best JA, Oosterhuis JA. Computer fluorophotometry. Doc Ophthalmol 56:89-97 (1983). PubMed
van Best JA, Putting BJ, Oosterhuis JA, Zweypfenning RC, Vrensen GF. Function and morphology of the retinal pigment epithelium after light-induced damage. Microsc Res Tech 36:77-88 (1997). PubMed
Van Best JA, Vandelft JF, Oosterhuis JA. Evaluation of a computer fluorophotometer for in vivo measurements. Ophthalmic Res 16:217-218 (1984).
Van Schaik HJ, Benitez del Castillo JM, Caubergh MJ, Gobert A, Leite E, Moldow B, Rosas V, Van Best JA. Evaluation of diabetic retinopathy by fluorophotometry. European concerted action on ocular fluorometry. Int Ophthalmol 22(2):97-104 (1998-1999). PubMed
Van Schaik HJ, Heintz B, Larsen M, Leite E, Rosas V, Schalnus R, Van Best JA. Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry. Graefes Arch Clin Exp Ophthalmol 235:639-646 (1997). PubMed
Vilser W, Schweitzer D, Konigsdorffer E, Jutte A. (Principal possibilities and limitation of fluorescein angiographic procedures for the measurement of the flow-physical magnitudes of the retinal circulatory system. Graefes Arch Clin Exp Ophthalmol (West Germany) 217:199-211 (1981). PubMed
Vine AK, Kisly AM, Betz AL, Howatt WF. Vitreous fluorophotometry in rats with streptozocin-induced diabetes. Arch Ophthalmol 102:1083-1085 (1984). PubMed
Walter WT, Dotterrer RM, Villalba M. Steroid effect on capillary permeability in gram-negative septic shock: Evaluation by vitreous fluorophotometry. Arch Surg 119:1021-1024 (1984). PubMed
Waltman S, Krupin T, Hanish S, Oestrich C, Becker B. Alteration of the blood-retinal barrier in experimental diabetes mellitus. Arch Ophthalmol 96:878-879 (1978). PubMed
Waltman SR, Krupin T, Kilo C, Becker B. Vitreous fluorophotometry in adult-onset diabetes mellitus. Am J Ophthalmol 88:342-345 (1979). PubMed
Waltman Sr, Krupin T, Singer P, Becker B. Effects of therapy on vitreous fluorophotometry in diabetes mellitus. Trans Ophthalmol Soc U.K. 99:8-9 (1979). PubMed
Waltman SR, Oestrich C, Krupin T, Hanish S, Ratzan S, Santiago J, Kilo C. Quantitative vitreous fluorophotometry: a sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients. Diabetes 27:85-87 (1978). PubMed
Waltman SR, Santiago J, Krupin T, Singer P, Becker, Bleicher S. Vitreous fluorophotometry and blood-sugar control in diabetics. Lancet 2:1068 (1979). PubMed
Waltman SR. Sequential vitreous fluorophotometry in diabetes mellitus: A five-year prospective study. Tr Am Ophth Soc 82:827-849 (1984). PubMed
White NH, Waltman SR, Krupin T, Santiago JV. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control. Diabetes 37:8-85 (1982). PubMed
White NH, Waltman SR, Krupin T, Santiago JV. Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control. J Pediatr 99:41-45 (1981). PubMed
Winkelman JZ, Zappia RJ, Gay AJ. Human arm to retina circulation time. Determination by simultaneous fluorophotometry. Arch Ophthalmol 86:626-636 (1971). PubMed
Yandrapu SK, Upadhyay AK, Petrash JM, Kompella UB. Nanoparticles in Porous Microparticles Prepared by Supercritical Infusion and Pressure Quench Technology for Sustained Delivery of Bevacizumab. Mol Pharm. Oct 16 (2013). PubMed
Yavuz B, Bozdağ Pehlivan S, Sümer Bolu B, Nomak Sanyal R, Vural İ, Ünlü N. Dexamethasone – PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation. J Pharm Pharmacol 68(8):1010-20 (2016). PubMed
Yoshida A, Feke GT, Morales-Stoppello J, Collas GD, Goger DG, McMeel JW. Retinal blood flow alterations during progression of diabetic retinopathy. Arch Ophthalmol 101:225-227 (1983). PubMed
Yoshida A, Furukawa H, Delori FC, Bursell SE, Trempe CL, McMeel JW. Effect of vitreous detachment on vitreous fluorophotometry. Arch Ophthalmol 102:857-860 (1984). PubMed
Yoshida A, Ishiko S, Kojima M. Inward and outward permeability of the blood-retinal barrier in experimental myopia. Graefes Arch Clin Exp Ophthalmol 234 Suppl 1:S239-S242 (1996). PubMed
Yoshida A, Kojima M. A simplified method for normalization of vitreous fluorophotometric readings by using protein-unbound fluorescein in the plasma. 1. Normalization of 60 min vitreous readings. Jpn J Clin Ophthalmol 38:1287-1291 (1984).
Zeimer RC, Blair NP, Cunha-Vaz JG. Methodology of vitreous fluorophotometry for clinical research. Draft.
Zeimer RC, Blair NP, Cunha-Vaz JG. Pharmacokinetic interpretation of vitreous fluorophotometry. Invest Ophthalmol Vis Sci 24:1374-1381 (1983). PubMed
Zeimer RC, Blair NP, Cunha-Vaz JG. Vitreous fluorophotometry for clinical research: I. Description and evaluation of a new fluorophotometer. Arch Ophthalmol 101:1753-1756 (1983). PubMed
Zeimer RC, Blair NP, Cunha-Vaz JG. Vitreous fluorophotometry for clinical research: II. Method of data acquisition and processing. Arch Ophthalmol 101:1757-1761 (1983). PubMed
Zeimer RC, Cunha-Vaz JG, Johnson ME. Studies on the technique of vitreous fluorophotometry. Invest Ophthalmol Vis Sci 22:668-674 (1982). PubMed
Zeimer RC, Cunha-Vaz JG. Evaluation and comparison of commercial vitreous fluorophotometers. Invest Ophthalmol Vis Sci (1981). PubMed
Zweig K, Cunha-Vaz J, Peyman G, et al. Effect of argon laser photocoagulation on fluorescein transport across the blood-retinal barrier. Exp Eye Res 32:323-329 (1981). PubMed
Zygulska-Mach H, Bryk E. (Diabetic Retinopathy.) Folia Med Cracov (Poland) 23:47-66 (1981). PubMed
For more information please send email brucei@ocumetrics.com
or call Bruce Ishimoto, OcuMetrics (650) 960-3955.